Celsion Corporation (NASDAQ: CLSN) plunged 81.55% to $1.48 on a traded volume of 24.20 million shares. The Company said that ThermoDox in combination with radiofrequency ablation did not meet the primary endpoint of the Phase III HEAT Study in patients with hepatocellular carcinoma, also known as primary liver cancer. Celsion has determined, after conferring with its independent Data Monitoring Committee that the HEAT Study did not meet the goal of demonstrating persuasive evidence of clinical effectiveness that could form the basis for regulatory approval in the population chosen for study.
IceWEB Inc (OTCQB: IWEB) increased 9.62% to $0.0570 on a traded volume of 2.85 million shares. The Company has signed its first Private Cloud customer, a Virginia County Government. IceWEB manufactures award-winning, high performance unified data storage appliances with enterprise storage management capabilities at a fraction of the price of traditional providers.
AMARANTUS BIOSCI INC (OTCQB: AMBS) moved up 1.35% to $0.0902 on a traded volume of 1.74 million shares. The Company has secured an additional $1.4 million of financing commitments through an amendment of the initial Convertible Note with Dominion Capital. The original $600,000 note, dated November 14, 2012, was amended to a face value of $2,000,000 before deducting placement agent fees and other offering expenses. The proceeds will be used to provide funding for Amarantus' lead asset Mesencephalic-Astrocyte-derived Neurotrophic Factor. Amarantus BioScience is a biotechnology company discovering and developing treatments and diagnostics for diseases associated with the neurodegeneration and apoptosis centered around its patented therapeutic protein MANF.
NanoTech Entertainment Inc (OTCPINK: NTEK) went down 4.21% to $0.0182 on a traded volume of 4.36 million shares. The Company announced Alan D. Stone has joined the Board of Directors of NanoTech Entertainment and the advisory board of the NanoTech Gaming Labs division.
Bio Matrix Scientific Group Inc (OTCPINK: BMSN) jumped up 10.81% to $0.0041 on a traded volume of 22.59 million shares. The 52-week range for the stock is $0.02 and $0.18. The 50-Day Moving Average and 200-Day Moving Average prices is $0.03 and $0.04 respectively. The Company is in the business of designing, developing and marketing medical devices, specifically disposable instruments used in stem cell extraction and tissue transfer procedures and operating cryogenic cellular storage facilities, specifically stem cell banking facilities.
Csrnewsdaily.com has a finger on the pulse of many sectors including renewable energy, oil, pharma, mining, finance, and healthcare. Our in depth research and analysis of NASDAQ, OTCBB, Pink Sheets, and NYSE has yielded considerable gains for our subscribers.
Our to-the-minute reports and alerts coupled with breaking news, analysis, investment strategies, and FREE subscription email services contribute to our role as one of the leading investor relations marketing firms.
The assembled information disseminated by Csrnewsdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Csrnewsdaily.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.
Pacific Dynasty Consultants Inc.
2637 E Atlantic Blvd #22611 Pompano Beach, FL 33062